Abiomed (ABMD) stock Forecast for 2022 – 2026
Last update: October 2, 2022 (10:35)
Sector: HealthcareThe share price of Abiomed, Inc. (ABMD) now
What analysts predict: $330
52-week high/low: $379.3 / $219.85
50/200 Day Moving Average: $273.47 / $286.84
This figure corresponds to the average price over the previous 50/200 days. For Abiomed stocks, the 50-day moving average is the resistance level today.
For Abiomed stocks, the 200-day moving average is the resistance level today.
Are you interested in Abiomed, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abiomed stock price in 2022, 2023, 2024, 2025, 2026. How much will one Abiomed share be worth in 2022 - 2026?
When should I take profit in Abiomed stock? When should I record a loss on Abiomed stock? What are analysts' forecasts for Abiomed stock? What is the future of Abiomed stock?
We forecast Abiomed stock performance using neural networks based on historical data on Abiomed stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Abiomed stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abiomed shares. This happens once a day.
Fresh insight into Abiomed stock
View all analyticsAbiomed: Correction Offers Good Buying Opportunity
Summary Abiomed’s Impella range of micro heart pumps enjoy rising demand in the marketplace. The company’s OXY-1 System cardiopulmonary support device has strong growth prospect. The company’s revenue will grow … Read more
Abiomed: Small Premium For Access To ~11% Normalized ROIC
Summary Abiomed came in with another set of robust earnings yesterday, with double-digit growth from top to bottom. Earnings remain steady, however, the company exhibits the profitability features investors are … Read more
Historical and forecast chart of Abiomed stock
The chart below shows the historical price of Abiomed stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abiomed stock price can be found in the table below.
Long-term forecasts by years.
Abiomed daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct 04 | 250.27 | 247.26 | 251.83 | 1.85 |
| Oct 05 | 251.89 | 248.75 | 253.53 | 1.92 |
| Oct 06 | 248.37 | 243.96 | 250.79 | 2.80 |
| Oct 07 | 250.17 | 248.54 | 252.30 | 1.51 |
| Oct 08 | 249.92 | 245.17 | 252.36 | 2.93 |
| Oct 09 | 248.67 | 244.57 | 251.16 | 2.69 |
| Oct 10 | 248.11 | 244.26 | 251.64 | 3.02 |
| Oct 11 | 245.63 | 241.15 | 250.42 | 3.85 |
| Oct 12 | 242.56 | 239.89 | 244.68 | 2.00 |
| Oct 13 | 243.16 | 241.34 | 245.60 | 1.76 |
| Oct 14 | 237.88 | 233.36 | 241.98 | 3.70 |
| Oct 15 | 243.76 | 239.25 | 245.29 | 2.52 |
| Oct 16 | 247.30 | 244.64 | 250.57 | 2.43 |
| Oct 17 | 247.54 | 244.45 | 250.76 | 2.58 |
| Oct 18 | 250.33 | 249.08 | 254.77 | 2.29 |
| Oct 19 | 253.52 | 249.34 | 258.34 | 3.61 |
| Oct 20 | 254.54 | 250.91 | 257.27 | 2.54 |
| Oct 21 | 251.74 | 248.34 | 255.51 | 2.89 |
| Oct 22 | 249.03 | 245.73 | 252.33 | 2.69 |
| Oct 23 | 250.65 | 249.27 | 252.53 | 1.31 |
| Oct 24 | 248.89 | 245.91 | 250.45 | 1.85 |
| Oct 25 | 245.91 | 242.16 | 250.82 | 3.58 |
| Oct 26 | 244.55 | 241.19 | 248.28 | 2.94 |
| Oct 27 | 245.65 | 240.80 | 248.17 | 3.06 |
| Oct 28 | 244.43 | 242.96 | 249.13 | 2.54 |
| Oct 29 | 247.73 | 245.19 | 250.76 | 2.27 |
| Oct 30 | 248.84 | 247.10 | 251.95 | 1.96 |
| Oct 31 | 247.29 | 243.51 | 251.06 | 3.10 |
| Nov 01 | 245.00 | 242.36 | 248.06 | 2.35 |
| Nov 02 | 238.87 | 234.28 | 240.55 | 2.68 |
Abiomed Daily Price Targets
Abiomed Stock Forecast 10-04-2022.
Pessimistic target level: 247.26
Optimistic target level: 251.83
Abiomed Stock Forecast 10-05-2022.
Pessimistic target level: 248.75
Optimistic target level: 253.53
Abiomed Stock Forecast 10-06-2022.
Pessimistic target level: 243.96
Optimistic target level: 250.79
Abiomed Stock Forecast 10-07-2022.
Pessimistic target level: 248.54
Optimistic target level: 252.30
Abiomed Stock Forecast 10-08-2022.
Pessimistic target level: 245.17
Optimistic target level: 252.36
Abiomed Stock Forecast 10-09-2022.
Pessimistic target level: 244.57
Optimistic target level: 251.16
ABMD (ABMD) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 265.35 | 258.36 | 274.60 | 5.91 |
| Nov. | 275.28 | 261.47 | 282.53 | 7.45 |
| Dec. | 278.32 | 263.65 | 290.62 | 9.28 |
Abiomed forecast for this year
Abiomed Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $265.353. Pessimistic: $258.36. Optimistic: $274.60
Abiomed Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $275.277. Pessimistic: $261.47. Optimistic: $282.53
Abiomed Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $278.319. Pessimistic: $263.65. Optimistic: $290.62
Abiomed (ABMD) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 267.20 | 252.44 | 275.60 | 8.41 |
| Mar | 249.94 | 235.49 | 257.38 | 8.50 |
| Mar | 260.35 | 248.40 | 266.55 | 6.81 |
| Apr | 276.50 | 258.17 | 290.37 | 11.09 |
| May | 264.99 | 248.32 | 282.33 | 12.05 |
| Jun | 261.38 | 254.94 | 266.94 | 4.49 |
| Jul | 255.39 | 250.18 | 266.02 | 5.96 |
| Aug | 247.79 | 236.62 | 253.90 | 6.80 |
| Sep | 240.42 | 230.40 | 245.12 | 6.00 |
| Oct | 248.39 | 233.18 | 260.42 | 10.46 |
| Nov | 249.02 | 233.14 | 255.79 | 8.85 |
| Dec | 259.18 | 244.64 | 271.08 | 9.75 |
Abiomed (ABMD) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 248.60 | 244.38 | 262.34 | 6.85 |
| Feb | 264.88 | 259.92 | 281.31 | 7.60 |
| Mar | 279.96 | 264.97 | 292.81 | 9.51 |
| Apr | 291.86 | 280.70 | 307.74 | 8.79 |
| May | 297.32 | 280.13 | 311.47 | 10.06 |
| Jun | 309.19 | 288.17 | 329.17 | 12.46 |
| Jul | 318.66 | 305.38 | 324.07 | 5.77 |
| Aug | 306.74 | 291.09 | 322.38 | 9.70 |
| Sep | 293.70 | 278.22 | 307.68 | 9.57 |
| Oct | 285.21 | 271.88 | 293.21 | 7.28 |
| Nov | 305.09 | 294.72 | 314.69 | 6.35 |
| Dec | 310.02 | 293.15 | 325.83 | 10.03 |
Abiomed (ABMD) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 305.54 | 286.58 | 315.41 | 9.14 |
| Mar | 307.10 | 297.96 | 326.68 | 8.79 |
| Mar | 307.62 | 287.49 | 317.03 | 9.32 |
| Apr | 288.53 | 277.50 | 307.42 | 9.73 |
| May | 291.48 | 286.03 | 307.58 | 7.01 |
| Jun | 289.99 | 284.07 | 299.60 | 5.18 |
| Jul | 311.93 | 299.20 | 329.16 | 9.10 |
| Aug | 314.31 | 305.23 | 332.21 | 8.12 |
| Sep | 311.91 | 296.53 | 321.72 | 7.83 |
| Oct | 312.17 | 304.21 | 319.87 | 4.89 |
| Nov | 305.54 | 292.29 | 323.46 | 9.63 |
| Dec | 321.90 | 310.96 | 339.69 | 8.46 |
Abiomed (ABMD) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 295.63 | 285.83 | 313.48 | 8.82 |
| Mar | 275.03 | 268.48 | 285.08 | 5.82 |
| Mar | 265.21 | 249.66 | 270.85 | 7.82 |
| Apr | 260.03 | 247.65 | 265.55 | 6.74 |
| May | 281.91 | 277.11 | 289.81 | 4.38 |
| Jun | 289.10 | 283.20 | 308.75 | 8.28 |
| Jul | 305.80 | 294.63 | 319.58 | 7.81 |
| Aug | 319.32 | 305.48 | 336.15 | 9.12 |
| Sep | 322.31 | 310.53 | 332.17 | 6.52 |
| Oct | 310.25 | 290.21 | 328.19 | 11.57 |
| Nov | 321.59 | 314.21 | 340.73 | 7.78 |
| Dec | 311.75 | 299.56 | 324.74 | 7.75 |
Abiomed information and performance
Abiomed is a manufacturer of medical implants, including the AbioCor artificial heart and impella. The company is headquartered in Danvers, Massachusetts and has three subsidiary offices: two in Germany in Berlin and Aachen and one in Japan. Michael R. Minogue joined Abiomed in 2004 and serves as CEO, Chairman and President.
Abiomed Address
22 CHERRY HILL DR, DANVERS, MA, US
Market Capitalization: 11 167 697 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 279 261 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 52.27
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 2.75
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 4.7
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.056
Quarterly Revenue Growth YOY: 0.097
Trailing PE: 52.27
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 9.77
Enterprise Value (EV) /Revenue
EV To EBITDA: 36.28
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 45460900
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A